Format

Send to

Choose Destination
Future Oncol. 2017 Dec;13(29):2697-2708. doi: 10.2217/fon-2017-0073. Epub 2017 Nov 23.

Hydrogel spacers in prostate radiotherapy: a promising approach to decrease rectal toxicity.

Author information

1
Department of Radiation Oncology, INOVA Health System Fairfax, 3300 Gallows Road, Falls Church, VA 22042, USA.
2
Department of Radiation Oncology, RWTH Aachen University, Pauwelsstrasse 30, 52057 Aachen, Germany.
3
Johns Hopkins Medicine, Department of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University, 401 N Broadway, Baltimore, MD 21231, USA.

Abstract

High-dose radiation is a well-established method of treatment for prostate cancer. The main limiting structure for dose escalation is the rectum. The risk of rectal toxicity is related to dose received by the rectum. Several strategies for reducing dose to rectum have been explored; these include endorectal balloons as well as injection of rectal spacers like hydrogels. They create greater distance between rectal wall and prostate to confer a dosimetric advantage to the rectum. Early clinical studies with hydrogels have shown favorable outcomes. A low incidence of major procedural adverse effects with hydrogel use has been reported and it is well tolerated by patients. Hydrogel holds promise in establishing itself as an adjunct to standard of care in prostate radiation.

KEYWORDS:

IMRT; dosimetry; hydrogel; proctitis; prostate; radiation; radiotherapy; rectum; spacer; toxicity

PMID:
29168659
DOI:
10.2217/fon-2017-0073
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center